Reduced-Intensity Stem Cell Transplantation
NCI Common Toxicity Criteria is appropriate in toxicity evaluation of RIST
Published in Cancer Weekly, December 21st, 2004
According to a study from Japan, "Acute regimen-related toxicity (RRT) is minimal in reduced-intensity stem-cell transplantation (RIST). However, the Seattle RRT grading (Bearman et al), developed in the context of conventional-intensity transplantation, is frequently applied to RIST."
"We compared the National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 2.0 with the Seattle criteria after RIST in 86 patients. RRT within 30 days of transplant graded by both sets of criteria were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-12-21)
More Articles from Cancer Weekly
- Acute Lymphoblastic Leukemia
Busulfan good alternative to TBI to improve quality of life in childhood ALL - Acute Promyelocytic Leukemia
Novel immunoassay provides rapid and accurate APL diagnosis - Lymphoma
Simian virus 40 not involved in lymphoma pathogenesis - Non-Hodgkin Lymphoma
Cancer risk appears lower with multiple pregnancies, higher with later menarche - Ovarian Cancer
DNA microarray expression profiling predicts chemotherapeutic response - Accreditation
Hospital achieves gold seal and disease specific certification from JCAHO - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
